Bombay HC Stays FDA Action Against Milk Vendors

The Bombay High Court has granted an interim stay on the Food and Drug Administration's (FDA) decision to suspend the licences of several milk suppliers and vendors in Chhatrapati Sambhajinagar.

This decision was made by the Aurangabad Bench of the High Court, which observed that due process of law was not followed in the suspension of the licences. The court held that the law mandates an improvement notice and an opportunity for a hearing before such drastic action is taken.

The FDA had suspended the petitioners' licences earlier this month for alleged violations of the Food Safety and Standards Act. However, the petitioners contended that only minor deficiencies had been found and that, under the law, an improvement notice ought to have been issued before any decision to suspend their licences.

The Bench observed that, in most cases, the deficiencies noted during FDA inspections were not serious enough to warrant the closure of milk processing units or the abrupt suspension of licences. The court also noted that the FDA officer had the power to suspend a licence without prior notice, but found no exigency warranting such drastic action without first issuing an improvement notice or providing the petitioners with an opportunity for a hearing.

Justice S.G. Chapalgaonkar passed the order last week in separate petitions filed by the aggrieved suppliers and vendors. The court issued notice to the FDA and granted an interim stay on the suspension orders, stating that the action under the impugned order was 'dehors' (beyond the scope of) the requisite procedure under Section 32 of the Food Safety and Standards Act.

Advocate Rahul Karpe, appearing for the petitioners, argued that a show-cause notice and an opportunity for a hearing should have been given before the licences were suspended. The government contended that the FDA officer had the power to suspend a licence without prior notice, but the court did not agree with this argument.

The High Court's decision is a significant one, as it highlights the importance of following due process of law in administrative decisions. The court's observation that the deficiencies noted during FDA inspections were not serious enough to warrant the closure of milk processing units or the abrupt suspension of licences is also noteworthy.

The decision will have implications for the milk suppliers and vendors in Chhatrapati Sambhajinagar, who will now be able to continue operating until the final decision is made. The FDA will also need to reconsider its decision and follow the due process of law in any future actions.

In conclusion, the Bombay High Court's decision to grant an interim stay on the FDA's decision to suspend the licences of milk suppliers and vendors is a significant one, highlighting the importance of following due process of law in administrative decisions. The decision will have implications for the milk suppliers and vendors, as well as the FDA, and will be closely watched in the coming days.

The case also raises questions about the powers of the FDA and the procedures that need to be followed in such cases. The court's decision is a reminder that administrative decisions must be made in accordance with the law and that due process must be followed at all times.

The Bombay High Court's decision is a victory for the milk suppliers and vendors, who will now be able to continue operating until the final decision is made. The decision is also a reminder of the importance of the judiciary in ensuring that administrative decisions are made in accordance with the law and that due process is followed at all times.

The implications of the decision will be far-reaching, and it will be interesting to see how the FDA responds to the court's decision. The case is a significant one, and it will be closely watched in the coming days.

In the end, the Bombay High Court's decision to grant an interim stay on the FDA's decision to suspend the licences of milk suppliers and vendors is a significant one, highlighting the importance of following due process of law in administrative decisions. The decision will have implications for the milk suppliers and vendors, as well as the FDA, and will be closely watched in the coming days.